All In Biotech

Drug Trial Radar · NCT04413942

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Apr 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

99

Actual

Start

Mar 10, 2020

Primary completion

Dec 31, 2021

Study completion Jun 30, 2022

Sponsor

Lead sponsor
Oneness Biotech Co., Ltd.Industry
Sponsor type
Industry
First posted
Jun 4, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aims to evaluate the efficacy, improvement from baseline in Eczema Area and Severity Index (EASI) score, of multiple intravenous (IV) doses of FB825 in subjects with atopic dermatitis

Conditions

  • Atopic Dermatitis

Interventions

  • FB825Biological

    Humanized monoclonal IgG1 specifically targeting the CεmX domain of membrane-bound IgE

  • PlaceboOther

    Formulation buffer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The mean change of Eczema Area and Severity Index [EASI] from baseline to Week 16Time frame: 16 weeks

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Zenith Research

    Beverly Hills, California

  • Encino Research Center

    Encino, California

  • Marvel Research 002, LLC

    Huntington Beach, California

  • Providence Clinical Research

    North Hollywood, California

  • ACRC Studies

    San Diego, California

  • Unison Clinical Trials

    Sherman Oaks, California

  • University Clinical Research - Deland, LLC

    DeLand, Florida

  • FXM Clinical Research Ft. Lauderdale, LLC.

    Fort Lauderdale, Florida

  • Sweet Hope Research Specialty

    Hialeah, Florida

  • Universal Axon - Homestead, LLC

    Homestead, Florida

  • FXM Clinical Research Miramar, LLC

    Miramar, Florida

  • FXM Clinical Research Miami, LLC

    Miramar, Florida

  • Moore Clinical Research

    Tampa, Florida

  • Avita Clinical Research (PCRS Network)

    Tampa, Florida

  • Oakland Hills Dermatology (PCRS Network)

    Auburn Hills, Michigan

  • Revival Research Institute, LLC

    Troy, Michigan

  • Paddington Testing Co, Inc

    Philadelphia, Pennsylvania

  • Clinical Research Partners

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.